JB Chemicals & Pharmaceuticals Limited
2,629words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ironment. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance or achievements of the Company
60%
cross multiple businesses Brands among top 300 brands (IQVIA MAT Mar’23 data), contributing over 60% of domestic formulations revenues Regulated/semi-regulated markets of presence through direct o
26%
butors Global manufacturer of medicated/herbal lozenges representing a substantial opportunity 26% 2500+ 8 21% Growth in chronic therapies* in the domestic formulations business Strong India
21%
manufacturer of medicated/herbal lozenges representing a substantial opportunity 26% 2500+ 8 21% Growth in chronic therapies* in the domestic formulations business Strong India field force# wi
21.3%
hot – Financial Overview Revenue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 3
18.6%
inancial Overview Revenue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410
15.4%
venue (INR cr) PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 F
27.4%
PAT (INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 FY21 FY22 FY2
25.0%
INR cr) ^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 FY21 FY22 FY23 42%
24.3%
^Op EBITDA Margin (%) ROE (%) ROCE (%) 21.3% 18.6% 1,643 1,775 15.4% 1,413 27.4% 25.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 FY21 FY22 FY23 42% 25% 2
42%
5.0% 24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 FY21 FY22 FY23 42% 25% 29% 19% 24% 13% # 22% 18% 21% 17% FY19 FY20 FY21 FY22 FY23 15% 10% FY18 Incr
25%
24.3% 3,149 2,043 2,424 139 194 272 449 386 410 FY18 FY19 FY20 FY21 FY22 FY23 42% 25% 29% 19% 24% 13% # 22% 18% 21% 17% FY19 FY20 FY21 FY22 FY23 15% 10% FY18 Increasin
Advertisement